Opexa Therapeutics, Inc. 4
4 · Opexa Therapeutics, Inc. · Filed Jul 2, 2013
Insider Transaction Report
Form 4
Warma Neil K
President & CEO
Transactions
- Award
Common Stock
2013-06-30$1.54/sh+581$895→ 9,239 total
Footnotes (1)
- [F1]On June 30, 2013, the reporting person was issued 581 shares of Common Stock as payment-in-kind for interest accrued as of June 30, 2013 on a 12% Convertible Secured Promissory Note held in the principal amount of $15,000. The shares issued in payment of accrued interest payable on the interest payment date were deemed to have a value equal to the volume weighted average price for the Common Stock for the five trading days ending three trading days prior to the payment date.